Clinical Study Evaluating the Gastroprotective Effect of Carvedilol in Patients With Ischemic Heart Disease on Aspirin Therapy
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05553717 |
Recruitment Status :
Not yet recruiting
First Posted : September 23, 2022
Last Update Posted : September 23, 2022
|
Sponsor:
Tanta University
Information provided by (Responsible Party):
Sarah Mohamed Elkablawy, Tanta University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Not yet recruiting |
---|---|
Estimated Primary Completion Date : | October 2023 |
Estimated Study Completion Date : | October 2023 |
Publications: